KRAS mutations drive adenomatoid odontogenic tumor

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

Objective: KRAS is the most frequently mutated onco gene in human neoplasms and we have previously reported KRAS p.G12V mutations in adenomatoid odontogenic tumors (AOT). We aimed to expand this cohort of samples and to test the association of KRAS mutations with clinical and histopatho logical parameters. A convenience sample of 30 AOT cases was included in the study. The hotpot KRAS p.G12V mutation was assessed by TaqMan allele-specific qPCR and codon 12 was direct sequenced. Clinical information obtained included patients age, tumor site, association of the lesion with impacted teeth and clinical tumor size. In addition, tumor capsule thickness was evaluated by morphometric analysis. Statistical analysis was car ried out to test the association of KRAS codon 12 mutations with clinico-pathological parameters. Findings: Molecular results confirmed KRAS p.G12V mutation in 14/23 cases, and p.G12R in 1/23. Eight cases were wild-type and samples from 7 cases failed amplification. Codon 12 mutations were not associated with any of the clinicopatho logical parameters tested (p>0.05). Conclusion: AOTshow high frequency of KRAS codon 12 mutations (15/23, 65%), which occur irrespectively of patients’ age, tumor location, association with impacted teeth, tumor clinical size or histopathological capsule thickness.

Abstract

Assunto

Association, Mutation, Codon, Oncogenes, Evaluation study

Palavras-chave

Citação

Curso

Endereço externo

https://www.oooojournal.net/article/S2212-4403(19)30327-X/fulltext

Avaliação

Revisão

Suplementado Por

Referenciado Por